351 related articles for article (PubMed ID: 23782712)
21. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
[TBL] [Abstract][Full Text] [Related]
22. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
23. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
[TBL] [Abstract][Full Text] [Related]
24. Axillary reverse mapping: five-year experience.
Ochoa D; Korourian S; Boneti C; Adkins L; Badgwell B; Klimberg VS
Surgery; 2014 Nov; 156(5):1261-8. PubMed ID: 25444319
[TBL] [Abstract][Full Text] [Related]
25. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
[TBL] [Abstract][Full Text] [Related]
26. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
Wijaya WA; Peng J; He Y; Chen J; Cen Y
Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
[TBL] [Abstract][Full Text] [Related]
27. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
[TBL] [Abstract][Full Text] [Related]
28. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
29. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
[TBL] [Abstract][Full Text] [Related]
30. The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer.
Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E
Breast Cancer; 2022 Mar; 29(2):209-215. PubMed ID: 34591289
[TBL] [Abstract][Full Text] [Related]
31. Axillary surgery for breast cancer: past, present, and future.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Ohno Y; Kurita T
Breast Cancer; 2021 Jan; 28(1):9-15. PubMed ID: 33165758
[TBL] [Abstract][Full Text] [Related]
32. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
33. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
34. Periclavicular Lymph Node Activation Maintains the Lymphatic Circulation of Upper Extremity Following Breast Cancer Surgery with Axillary Lymph Node Dissection.
Kang SH; Lee DG
Lymphat Res Biol; 2021 Jun; 19(3):256-260. PubMed ID: 32986507
[No Abstract] [Full Text] [Related]
35. Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.
Yuan Q; Wu G; Xiao SY; Hou J; Ren Y; Wang H; Wang K; Zhang D
Ann Surg Oncol; 2019 Oct; 26(11):3446-3454. PubMed ID: 31240591
[TBL] [Abstract][Full Text] [Related]
36. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
[TBL] [Abstract][Full Text] [Related]
37. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Che Bakri NA; Kwasnicki RM; Khan N; Ghandour O; Lee A; Grant Y; Dawidziuk A; Darzi A; Ashrafian H; Leff DR
Ann Surg; 2023 Apr; 277(4):572-580. PubMed ID: 35946806
[TBL] [Abstract][Full Text] [Related]
38. Axillary reverse mapping for breast cancer.
Noguchi M
Breast Cancer Res Treat; 2010 Feb; 119(3):529-35. PubMed ID: 19842033
[TBL] [Abstract][Full Text] [Related]
39. The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema.
Ruffino AE; Madera JD; Dearborn MM; Frank K; Oxenberg JC
Am Surg; 2024 Feb; 90(2):199-206. PubMed ID: 37619219
[TBL] [Abstract][Full Text] [Related]
40. [Axillary reverse mapping--chance to prevent lymphedema in breast cancer patients].
Pavlista D; Koliba P; Eliska O
Ceska Gynekol; 2011 Oct; 76(5):355-9. PubMed ID: 22132635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]